Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms

European Journal of Dermatology

Volumn 9, Issue 8, 1999, Pages 657-663

  Bircher, Andreas J ^a  

^a Universitatsspital Basel Dermatologie   (Switzerland)

Author keywords

ACE inhibitors; Adverse drug reaction; Angioedema; Idiosyncrasy; Nonsteroidal antiinflammatory drugs; Pathomechanism; Pseudoallergy; Urticaria

Indexed keywords

ANTIBIOTIC AGENT; CONTRAST MEDIUM; DEXTRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIRUDIN; IMMUNOGLOBULIN E; LOCAL ANESTHETIC AGENT; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTAMINE; THIAMINE;

ANGIONEUROTIC EDEMA; ARTICLE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; HUMAN; HYPERSENSITIVITY REACTION; IMMUNOPATHOLOGY; PATHOPHYSIOLOGY; URTICARIA;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HUMANS; URTICARIA;

EID: 0033456202     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. 1. Garcia JJ, Blanca M, Moreno F, Vega JM, Mayorga C, Fernandez J, et al. Determination of IgE antibodies to the benzylpenicilloyl determinant: A comparison of the sensitivity and specificity of three radio allergo sorbent test methods. J Clin Lab Analysis 1997; 11: 251-7.
2. 2. Shepherd GM. Allergy to bêta-lactam antibiotics. Immunol Allergy Clin North America 1991; 11: 611-33.
3. 3. Weiss ME, Adkinson NF. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy 1988; 18: 515-40.
4. 4. Rieder MJ, Uetrecht JP, Shear NH, Cannon M, Miller M. Diagnosis of sulfonamide hypersensitivity reactions by in vitro 'rechallenge' with hydroxylamine metabolites. Ann Intern Med 1989; 110: 286-9.
5. 5. Rieder MJ. Immunopharmacology and adverse drug reactions. J Clin Pharmacol 1993; 33: 316-23.
6. 6. Shear N, Spielberg SP, Cannon M, Miller M. Anticonvulsant hypersensitivity syndrome. J Clin Invest 1988; 82: 1826-32.
7. 7. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104: 5-13.
8. 8. Ownby DR. Acetaminophen-induced urticaria and tolerance of ibuprofen in an eight-year-old child. J Allergy Clin Immunol 1997; 99: 151-2.
9. 9. Arias J, Fernández-Rivas M, Moral A, García MA, Senent CJ. Selective adverse reactions to diflunisal. Ann All Asthma Immunol 1995; 74: 160-2.
10. 10. GISED. Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Dermatology 1993; 186: 164-9.
11. 11. Senna GE, Passalacqua G, Andri G, Dama AR, Albano M, Fregonese L, et al. Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs. Drug Safety 1996; 14: 94-103.
12. 12. Schwarz N, Ham Pong A. Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: a case report. Ann Allergy Asthma Immunol 1996; 77: 473-4.
13. 13. Stevenson DD. Aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North America 1995; 15: 529-52.
14. 14. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M. Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998; 28: 1153-8.
15. 15. Quiralte J, Sánchez-Gracía F, Torres MJ, Blanco C, Castillo R, Ortega N, et al. Association of HLA-DR11 with the anaphylactoid reaction caused by nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1999; 103: 685-9.
16. 16. van Wijk RG, Groot HD, Bogaard JM. Drug-dependent exercise-induced anaphylaxis. Allergy 1995; 50: 992-4.
17. 17. Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin immunol 1996; 98: 678-85.
18. 18. Quiralte J, Blanco C. New trends in aspirin sensitivity. Clin Exp Allergy 1998; 28: 55-6.
19. 19. Corominas M. Mechanisms implicated in adverse reactions to non-steroidal anti-inflammatory drugs. Clin Exp Allergy 1998; 28: 41-5.
20. 20. Dahlen B, Margolskee DJ, Zetterström O, Dahlen SE. The leukotriene receptor antagonist MK-0679 blocks airway obstruction induce by inhaled lysine-aspirine in aspirine-sensitive asthmatics. Eur Respir J 1993; 6: 1018-26.
21. 21. Menendez R, Venzor J, Ortiz G. Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis. Ann Allergy Asthma Immunol 1997; 80: 225-6.
22. 22. Enrique E, García-Ortega P, Gaig P, San Miguel MM. Failure of montelukast to prevent anaphyalxis to diclofenac. Allergy 1999; 54: 529-30.
23. 23. Ohnishi-Inoue Y, Mitsuya K, Horio T. Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist. Br J Dermatol 1998; 138:483-5.
24. 24. Spector S, Tan R. Antileukotrienes in chronic urticaria. J Allergy Clin Immunol 1998; 101: 572.
25. 25. Reuss-Borst M. Selektive Cyclooxygenase-2 (COX-2)-Hemmer. Internist 1997; 38: 266-71.
26. 26. Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 1998; 53: 1231-3.
27. 27. Przybilla B, Bonnländer AR, Ring J. Anaphylactoid reactions to mild analgesics. In: Ring J, Burg G, editors. New trends in allergy II. Berlin: Springer; 1986. p. 262-71.
28. 28. Vieluf D, Przybilla B, Schwerbrock U, Ring J. Oral provocation test in the diagnosis of anaphylactoid reactions to 'mild' analgesic preparations. Int Arch Allergy Appl Immunol 1995; 107: 268-71.
29. 29. Hein UR, Chantraine-Hess S, Worm M, Zuberbier T, Henz BM. Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. Acta Derm Venereol (Stockh) 1999; 79: 139-42.
30. 30. Vives R, Canto G, Rosado A, Rodriguez J. NSAIDS intolerance: Clinical and diagnostic aspects. Clin Exp Allergy 1998; 28: 53-4.
31. 31. Czech W, Schöpf E, Kapp A. Release of sulfidoleukotrienes in vitro: Its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflamm Res 1995; 44: 291-5.
32. 32. Wedi B, Kapp A. Wertigkeit des zellulären Antigenstimulationstests (CAST). Hautarzt 1997; 48: 347-8.
33. 33. Zollner TM, Röder C, Werner RJ, Diehl S, Kaufmann R. Cellular antigen stimulation test in the diagnosis of intolerance to non-steroidal antiinflammatory drugs. Eur J Dermatol 1997; 7: 377-8.
34. 34. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991; 88: 830-7.
35. 35. Douglas DM, Ward L, Brown JS. Nonsteroidal antiinflammatory drug desensitization using flurbiprofen (Ansaid). Ann Allergy 1993; 71: 459-60.
36. 36. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes. J Allergy Clin Immunol 1996; 98: 751-8.
37. 37. Tobia CN, Krinzman SJ, Penrose JF, Bloch KJ, MacLean JA, Wong JT. Rapid oral challenge/desensitization for patients with aspirin (ASA)-induced urticaria/angioedema. J Allergy Clin Immunol 1999; 103: S37.
38. 38. Smit AJ, van der Loan S, de Monchy J, Kallenberg CGM, Donker AJM. Cutaneous reactions to captopril. Clin Allergy 1984; 14: 413-9.
39. 39. Kitamura K, Aihara M, Osawa J, Naito S, Ikezawa Z. Sulfhydril drug-induced eruption: a clinical and histological study. J Dermatol 1990; 17: 44-51.
40. 40. Mignat C, Unger T. ACE Inhibitors. Drug interactions of clinical significance. Drug Safety 1995; 12: 334-47.
41. 41. Mathias B, Lasek R, Piper C. Allergische und pseudo-allergische Nebenwirkungen von Arzneimitteln, insbesondere von ACE-Hemmern. Allergologie 1994; 17: 457-62.
42. 42. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA 1997; 278: 232-3.
43. 43. Pigman EC, Scott JL. Angioedema in the emergency department: the impact of angiotensin-converting enzyme inhibitors. Am J Emerg Med 1993; 11: 350-4.
44. 44. Gabb GM, Ryan P, Wing LM, Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med 1996; 26: 777-82.
45. 45. Schiller P, Langauer Messmer S, Haefely WE, Schlienger R, Bircher AJ. Angiotensin-converting enzyme inhibitor induced angioedema. Late onset, irregular course and potential role of triggers. Allergy 1997; 52: 432-5.
46. 46. Gregory KWP, Davis RC. Angioedema of the intestine. N Engl J Med 1996; 334: 1641.
47. 47. Abdelmalek MF, Douglas DD. Lisinopril-induced isolated visceral angioedema: review of ACE-inhibitor-induced small bowel angioedema. Dig Dis Sci 1997; 42: 847-50.
48. 48. Jacobs RL, Hoberman LJ, Goldstein HM. Angioedema of the small bowel caused by an angiotensin-converting enzyme inhibitor. Am J Gastroenterol 1994; 89: 127-8.
49. 49. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-edema. Lancet 1998; 351: 1693-7.
50. 50. Sigler C, Annis K, Cooper K, Haber H, van de Carr S. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor. Arch Dermatol 1997; 133: 972-5.
51. 51. Agostoni A, Cicardi M. Contraindications to the use of ACE inhibitors in patients with C1 esterase inhibitor deficiency. Am J Med 1991; 90: 278.
52. 52. Brown N, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996; 60: 8-13.
53. 53. Gainer JV, Nadeau JH, Ryder D, Brown NJ. Increased sensitivity to bradykinin among African Americans. J Allergy Clin Immunol 1997; 98: 283-7.
54. 54. Vleeming W, van Amsterdam JCG, Stricker BHC, de Wildt DJ. ACE Inhibitor-induced angioedema. Incidence, prevention and management. Drug Safety 1998; 18: 171-88.
55. 55. Sabroe RA, Kobza Black A. Angiotensin-converting enzyme (ACE) inhibitors and angioedema. Br J Dermatol 1997; 136: 153-8.
56. 56. Maier C. Lebensbedrohliches postoperatives Angioödem nach Einnahme von ACE-Hemmern. Anaesthesist 1995; 44: 875-9.
57. 57. Langauer Messmer S, Schiller P, Bircher AJ. Glottic angioedema, ciprofloxacin, and angiotensin-converting enzyme inhibitors [letter]. Postgrad Med J 1996; 72: 383.
58. 58. Ulmer JL, Garvey MJ. Fatal angioedema associated with lisinopril. Ann Pharmacother 1992; 26: 1245-6.
59. 59. Giannoccaro PJ, Wallace GJ, Higginson LAJ, Williams WL. Fatal angioedema associated with enalapril. Can J Cardiol 1989; 5: 335-6.
60. 60. Singer DRJ, MacGregor GA. Angioneurotic oedema associated with two angiotensin converting enzyme inhibitors. Br Med J 1986; 293: 1243.
61. 6T. McElligott S, Perlroth M, Raish L. Angioedema after substituting lisinopril for captopril [letter]. Ann Intern Med 1992; 116: 426-7.
62. 62. Acker CA, Greenberg A. Angioedema induced by the angiotensin II blocker losartan. N Engl J Med 1995; 333: 1572.
63. 63. Boxer M. Accupril-and Cozaar-induced angioedema in the same patient. J Allergy Clin Immunol 1996; 98: 471.
64. 64. Frye CB, Pettigrew TJ. Angioedema and photosensitive rash induced by valsartan. Pharmacotherapy 1998; 18: 866-8.
65. 65. Sharma PK, Yium JJ. Angioedema associated with angiotensin II receptor antagonist losartan. South Med J 1997; 90: 552-3.
66. 66. van Rijnsoever EW, Kwee Zuiderwijk WJ, Feenstra J. Angioneurotic edema attributed to the use of losartan. Arch Intern Med 1998; 158: 2063-5.
67. 67. Hedner T, Samuelsson O, Lindholm L, Andrén L, Wiholm BE. Precipitation of angioedema by antihypertensive drugs. J Hypertension 1991; 9: S360-S1.
68. 68. Amon U. Pathophysiologische und immunologische Mechanismen kontrastmittelinduzier-ter anaphylaktoider Sofortreaktionen - eine Übersicht. Aktuelle Radiol 1997; 7: 145-8.
69. 69. Bush WHJ, Swanson DP. Radiocontrast. Immunol Allergy Clin North America 1995; 15: 597-612.
70. 70. Mita H, Tadokoro K, Akiyama K. Detection of IgE antibody to a radiocontrast medium. Allergy 1998; 53: 1133-40.
71. 71. Laroche D, Aimone Gastin I, Dubois F, Huet H, Gerard P, Vergnaud MC, et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 1998; 209: 183-90.
72. 72. Brockow K, Ring J. Anaphylaktoide Reaktionen nach Infusion von Röntgenkontrastmittel. Allergologie 1997; 20: 400-6.
73. 73. Renz H. Immunopathological mechanisms of delayed allergy-like reactions to contrast media: a theoretical overview. Eur Radiol 1996; 6: S3-S7.
74. 74. Courvoisier S, Bircher AJ. Delayed-type hypersensitivity to a nonionic, radioopaque contrast media. Allergy 1998; 53: 1221-4.
75. 75. Moneret-Vautrin D, Laxenaire MC. The risk of allergy related to general anaesthesia. Clin Exp Allergy 1993; 23: 629-33.
76. 76. Birnbaum J, Vervloet D. Allergy to muscle relaxants. Clin Rev Allergy 1991; 9: 281-93.
77. 77. Baldo BA, Pham NH. Structure-activity studies on drug-induced anaphylactic reactions. Chem Res Toxicol 1994; 7: 704-21.
78. 78. Thomas H, Eledjam JJ, Macheboeuf M, d'Athis F, Mares P, Bousquet J. Rapid pre-operative immunotherapy in a patient allergic to muscle relaxants. Eur J Anaesthesiol 1988; 5: 385-9.
79. 79. Eggleston ST, Lush LW. Understanding allergic reactions to local anesthetics. Ann Pharmacother 1996; 30: 851-7.
80. 80. Soto-Aguilar MC, deShazo RD, Dwason ES. Approach to the patient with suspected local anesthetic sensitivity. Immunol Allergy Clin North Am 1998; 18: 759-72.
81. 81. Cuesta Herranz J, De las Heras M, Fernández M, Lluch M, Figueredo E, Umpierrez A, et al. Allergic reaction caused by local anesthetic agents belonging to the amide group. J Allergy Clin Immunol 1997; 99: 427-8.
82. 82. Bircher AJ, Langauer Messmer S, Surber C, Rufli T. Delayed type hypersensitivity to subcutaneous lidocaine with tolerance of articaine. Confirmation by in vivo and in vitro tests. Contact Dermatitis 1996; 34: 387-9.
83. 83. Kraft D, Hédin H, Richter W, Schneider O, Rumpold H, Devey ME. Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and nonreactors to clinical dextran. Allergy 1982; 37: 481-9.
84. 84. Ljungström KG. Safety of dextran in relation to other colloids. Infusionsther Transfusions-med 1993; 20: 206-10.
85. 85. Bircher AJ, Hédin H, Berglund A. Probable grade IV dextran-induced anaphylactic reaction despite hapten inhibition. J Allergy Clin Immunol 1995; 92: 633-4.
86. 86. Weiss ME, Adkinson NFJ. Allergy to protamine. Clin Rev Allergy 1991; 9: 339-55.
87. 87. Weiss ME, Nyhan D, Peng Z, Horrow JC, Lowenstein E, Hirshman C, et al. Association of protamine IgE and IgG antibodies with life threatening reactions to intravenous protamine. N Engl J Med 1989; 320: 886-92.
88. 88. Proebstle TM, Jugert FK, Merk HF. Severe anaphylactic reaction to topical administration of framycetin. J Allergy Clin Immunol 1995; 96: 429-30.
89. 89. Bircher AJ, Czendlik CH, Langauer Messmer S, Müller P, Howald H. Acute urticaria from subcutaneous recombinant hirudin. J Allergy Clin Immunol 1996; 98: 994-6.
90. 90. Langauer Messmer S, Bircher AJ. Überempfindlichkeitsreaktionen auf Angiotensin-converting-enzyme-Hemmer. Allergologie 1997; 20: 393-9.